The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1517
March 27, 2017
View Complete Issue         Table of Contents 2019 
Exablate Neuro for Essential Tremor
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Exablate Neuro for Essential Tremor
March 27, 2017 (Issue: 1517)
The FDA has approved use of Exablate Neuro (Insightec) for unilateral thalamotomy to treat medication-refractory essential tremor in patients ≥22 years old. Exablate Neuro uses magnetic resonance-guided focused ultrasound (MRgFUS) to create...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Exablate Neuro for Essential Tremor
Article code: 1517c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.